These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 31940887)

  • 1. Progress of Induced Pluripotent Stem Cell Technologies to Understand Genetic Epilepsy.
    Sterlini B; Fruscione F; Baldassari S; Benfenati F; Zara F; Corradi A
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31940887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Cytomegalovirus Compromises Development of Cerebral Organoids.
    Brown RM; Rana PSJB; Jaeger HK; O'Dowd JM; Balemba OB; Fortunato EA
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31217239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. iPSCs-Based Neural 3D Systems: A Multidimensional Approach for Disease Modeling and Drug Discovery.
    Costamagna G; Andreoli L; Corti S; Faravelli I
    Cells; 2019 Nov; 8(11):. PubMed ID: 31739555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain Organoids: Expanding Our Understanding of Human Development and Disease.
    Chuye LB; Dimitri A; Desai A; Handelmann C; Bae Y; Johari P; Jornet JM; Klejbor I; Stachowiak MK; Stachowiak EK
    Results Probl Cell Differ; 2018; 66():183-206. PubMed ID: 30209660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using Patient-Derived Induced Pluripotent Stem Cells to Model and Treat Epilepsies.
    Du X; Parent JM
    Curr Neurol Neurosci Rep; 2015 Oct; 15(10):71. PubMed ID: 26319172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concise Review: Exciting Cells: Modeling Genetic Epilepsies with Patient-Derived Induced Pluripotent Stem Cells.
    Tidball AM; Parent JM
    Stem Cells; 2016 Jan; 34(1):27-33. PubMed ID: 26373465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic Characterization of Structural, Molecular, and Electrophysiological Phenotypes of Human-Induced Pluripotent Stem Cell-Derived Cerebral Organoids, and Comparison with Fetal and Adult Gene Profiles.
    Logan S; Arzua T; Yan Y; Jiang C; Liu X; Yu LK; Liu QS; Bai X
    Cells; 2020 May; 9(5):. PubMed ID: 32456176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of induced pluripotent stem cells in epilepsy.
    Hirose S; Tanaka Y; Shibata M; Kimura Y; Ishikawa M; Higurashi N; Yamamoto T; Ichise E; Chiyonobu T; Ishii A
    Mol Cell Neurosci; 2020 Oct; 108():103535. PubMed ID: 32758699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling human diseases with induced pluripotent stem cells: from 2D to 3D and beyond.
    Liu C; Oikonomopoulos A; Sayed N; Wu JC
    Development; 2018 Mar; 145(5):. PubMed ID: 29519889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Channeling' therapeutic discovery for epileptic encephalopathy through iPSC technologies.
    Simkin D; Ambrosi C; Marshall KA; Williams LA; Eisenberg J; Gharib M; Dempsey GT; George AL; McManus OB; Kiskinis E
    Trends Pharmacol Sci; 2022 May; 43(5):392-405. PubMed ID: 35427475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells.
    Ho BX; Pek NMQ; Soh BS
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling genetic epilepsies in a dish.
    Niu W; Parent JM
    Dev Dyn; 2020 Jan; 249(1):56-75. PubMed ID: 31241228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening Platforms for Genetic Epilepsies-Zebrafish, iPSC-Derived Neurons, and Organoids.
    Shcheglovitov A; Peterson RT
    Neurotherapeutics; 2021 Jul; 18(3):1478-1489. PubMed ID: 34595731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scalable Generation of Mature Cerebellar Organoids from Human Pluripotent Stem Cells and Characterization by Immunostaining.
    Silva TP; Fernandes TG; Nogueira DES; Rodrigues CAV; Bekman EP; Hashimura Y; Jung S; Lee B; Carmo-Fonseca M; Cabral JMS
    J Vis Exp; 2020 Jun; (160):. PubMed ID: 32597849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptome analysis and functional characterization of cerebral organoids in bipolar disorder.
    Kathuria A; Lopez-Lengowski K; Vater M; McPhie D; Cohen BM; Karmacharya R
    Genome Med; 2020 Apr; 12(1):34. PubMed ID: 32306996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of iPSC-derived Human Brain Organoids to Model Early Neurodevelopmental Disorders.
    Gabriel E; Gopalakrishnan J
    J Vis Exp; 2017 Apr; (122):. PubMed ID: 28448044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly efficient methods to obtain homogeneous dorsal neural progenitor cells from human and mouse embryonic stem cells and induced pluripotent stem cells.
    Zhang M; Ngo J; Pirozzi F; Sun YP; Wynshaw-Boris A
    Stem Cell Res Ther; 2018 Mar; 9(1):67. PubMed ID: 29544541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of induced pluripotent stem cell technologies in spinal cord injury.
    Nagoshi N; Okano H
    J Neurochem; 2017 Jun; 141(6):848-860. PubMed ID: 28199003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optogenetics reveal delayed afferent synaptogenesis on grafted human-induced pluripotent stem cell-derived neural progenitors.
    Avaliani N; Sørensen AT; Ledri M; Bengzon J; Koch P; Brüstle O; Deisseroth K; Andersson M; Kokaia M
    Stem Cells; 2014 Dec; 32(12):3088-98. PubMed ID: 25183299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Evolving Role of Induced Pluripotent Stem Cells and Cerebral Organoids in Treating and Modeling Neurosurgical Diseases.
    Jovanovich N; Habib A; Kodavali C; Edwards L; Amankulor N; Zinn PO
    World Neurosurg; 2021 Nov; 155():171-179. PubMed ID: 34454068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.